NJ Stock Epinephrine Bill Needs Your Help!

New Jersey is one of only six states that still has not passed school stock epinephrine legislation, though such legislation has passed the assembly and is pending in the senate.

With the holidays upon us, the Asthma and Allergy Foundation of America (AAFA) has issued the following call to action:

Dear Advocate,

The New Jersey Senate is currently considering a bill (S801) that would require schools in the state to keep a supply of undesignated epinephrine auto-injectors for use in emergencies. If a student experiences a severe allergic reaction (anaphylaxis), schools would be able to treat the potentially life-threatening reaction with the necessary medication.

The New Jersey Assembly has already passed the Assembly version of this bill, so if the Senate approves S801 the bill would go to Governor Christie for a signature!

Please click here to learn more about S801 and to send a letter to Senator Sweeney (the Senate President) urging him to bring the bill to a vote before the full Senate. We are one step closer to making schools in New Jersey safer for children with allergies!

Sincerely,
AAFA

We urge all NJ residents to send a message of support for S801 to Senator Stephen Sweeney and demand the bill be brought to a vote. You can do so by clicking here.

Please share this message using the buttons below with your friends and relatives that are NJ residents and ask them to send a message of support as well.

Print or share this article
Click to visit sponsor

2 COMMENTS

LEAVE A REPLY